The time a patient is in a doctor's office represents a very small window of the body normally, which makes out-of-office blood pressure measurements important to confirm diagnosis of hypertension, explained Paul Whelton, MD, MSc, professor of global public health at Tulane University.
The time a patient is in a doctor's office represents a very small window of the body normally, which makes out-of-office blood pressure measurements important to confirm diagnosis of hypertension, explained Paul Whelton, MD, MSc, professor of global public health at Tulane University.
Transcript
The new hypertension guideline emphasizes the need for measuring blood pressure when patients are not in the physician's office. Why is this important?
The measurement is very important. Obviously, we're going to make key decisions to label somebody as having high blood pressure and to maybe instigate therapy—lifestyle or drugs. And so we emphasize accurate measurements of blood pressure. we emphasize getting the average estimate of blood pressure, and we emphasize out-of-office blood pressure measurements, because we realize that once you get in the office, there's a very narrow window of what the body sees. So, it's important to get out-of-office measures to confirm the diagnosis of hypertension in the office, and to recognize white coat hypertension, or to recognize, more importantly, masked hypertension.
So for all of those reasons, we've put a strong emphasis on out-of-office blood pressure measurements. And, of course, in the United States, that's mostly going to be home blood pressure measurements, so the patient needs to be instructed how to get accurate measuremnts.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More